Latest News about Ino
Recent news which mentions Ino
Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 22, 2022
From Benzinga
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
December 20, 2022
From Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
December 19, 2022
From Benzinga
Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs
November 18, 2022
Tickers
INO
From Benzinga
3 Stocks to Avoid Right Now
November 17, 2022
From Motley Fool
Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript
November 08, 2022
Tickers
INO
From Motley Fool
What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours
November 08, 2022
Tickers
INO
From Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
November 03, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today
October 28, 2022
From Motley Fool
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
October 18, 2022
From Benzinga
Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday
October 17, 2022
Tickers
INO
From Motley Fool
Inovio Pharma Highlights Early Data From Experimental Drug For Respiratory Tract Disease
October 13, 2022
Tickers
INO
From Benzinga
Philips, Owens & Minor And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
October 12, 2022
From Benzinga
Tesla, Credit Suisse And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
October 03, 2022
From Benzinga
1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals
September 11, 2022
Tickers
INO
From Motley Fool
From Benzinga
From Benzinga
Inovio Pharmaceuticals (INO) Q2 2022 Earnings Call Transcript
August 10, 2022
Tickers
INO
From Motley Fool
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
From Benzinga
From Benzinga
From Benzinga
1 Beaten-Down Growth Stock To Avoid Like the Plague
July 24, 2022
From Motley Fool
After Slashing Costs, Is Inovio a Buy?
July 22, 2022
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
